Report Id: SNS/HC/2242 | July 2022 | Region: Global | 131 Pages
Pharmaceutical Gelatin Market Overview:
The Pharmaceutical Gelatin Market Size was valued at USD 1.1 billion in 2021, and expected to reach USD 1.6 billion by 2028, and grow at a CAGR of 5.4% over the forecast period 2022-2028.
Pharmaceutical gelatin, which is often made from collagen that is derived from animal body parts, is a translucent, lasting, naturally pleasant, flavorless food product. It is delicate when dry and springy when wet. As gelling agents, drugs, vitamins, and medications, photographic prints, films, and documents are frequently utilised. The firm gelatin capsules are created by dipping them into a heated gelatin solution, drying them, pinning them, cutting the cap and bodies, and joining them together for distribution. Pharmaceutical or supplemental health companies create hard gelatin capsules, which are subsequently filled with dosages of their medications, often in dry form. The soft gelatin phase begins with the production of two soft gelatin sheets, each of which crosses a die to produce the required size and shape of a capsule.
When the capsules are created, the drug or nutritional supplements are simultaneously filled with a fluid dose. A binding agent may be used in the dose and layer to get rid of unpleasant flavors and odors. Additionally, it enables product identity through design. The gradual and quick release of medications is also greatly aided by the gelatin-specific breakdown. It is also employed in the production of suppositories.
Gelatin is more versatile and superior in pharmaceutical applications.
Gelatin is a completely natural substance that complies with medical laws.
Veganism is becoming more popular.
Pharmaceutical gelatin production is constrained in some areas by cultural constraints.
In emerging nations, there is an increasing need for pharmaceutical-grade gelatin.
The range of gelatin's medicinal applications is expanded by improvements to its characteristics.
Increasing instances of diseases transmitted by animals
Increasing costs and limited supply of basic resources
IMPACT OF COVID-19
Global demand for pharmaceutical products has been fueled by COVID-19's increasing prevalence. However, the lockdown and quarantine measures implemented in various areas have led to transport and logistics challenges, making it challenging to obtain the raw materials for pharmaceutical gelatin. Due to this, there is a supply-demand imbalance for pharmaceutical gelatin in some regions. India and China, who have experienced protracted lockdowns, have been harmed more severely than other nations like the US and EU members. This impact, meanwhile, is only anticipated to last a short while before returning to normal after Covid 19.
Tablets, hard and soft gel capsules, absorbable Hemostats, as well as other uses, make up the pharmaceutical gelatin industry. The benefits of soft gel capsules, such as their capacity to be made correctly for rapid or gradual release and high degree of repeatability, make them a patient-friendly dosage form with a rapid growth rate. In the application segment of the pharmaceutical gelatin market, soft gel capsules have experienced a high growth rate over the anticipated period due to these factors.
Pork, bovine skin, marine, bovine bone, and poultry gelatin are the different market segments for medicinal gelatin. During the forecast period, it is predicted that the porcine segment will increase at the fastest rate. The range of uses in the pharmaceutical industry, absorbable hemostats, and other biomedical applications, combined with lower production costs and a quicker manufacturing cycle, are all factors that are boosting this market's growth.
Stabilizing, thickening, gelling, and other functions are the different market segments for medicinal gelatin. Since it is used in pharmaceutical syrups, elixirs, and other liquid dosage forms, the thickening market is predicted to expand at the fastest rate. Gelatin is additionally employed to make the dose form viscous while maintaining its other qualities. This market is expanding due to the use of gelatin as a thickening factor in antibacterial creams and lotions.
Markets for Type A and Type B pharmaceutical gelatin are separated. The Type B segment's significant market share throughout the forecast period can be attributable to the rising desire for using bovine bone in the production of pharmaceutical gelatin and cultural acceptance of bovine source.
Some of the major key players are as follows: Capsugel, Gelita AGv, Catelent Inc., Rousselot, Sterling Gelatin, Norland Products Inc, Weishardt, Tessenderlo Group, Roxlor llc, Nitta Gelatin Inc, and other players.
Gelling agents & Other Functions
During the projected period, the Asia Pacific region's pharmaceutical gelatin market is anticipated to expand at the highest CAGR. Due to the abundance of porcine and bovine raw material sources, as well as the region's low labour and capital investment costs, key market players are making investments here. The Asia Pacific region is expected to increase as a result of these factors throughout the forecast period.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2021||US$ 1.1 Billion|
|Market Size by 2028||US$ 1.6 Billion|
|CAGR||CAGR of 5.4% From 2022 to 2028|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Application (Hard Capsules, Soft Capsules, Tablets, Absorbable Hemostats)
• By Source (Porcine, Bovine Skin, Bovine Bone, Marine, Poultry)
• By Function (Stabilizing agents, Thickening agents, Gelling agents & Other Functions)
• By Type (Type A, Type B)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Capsugel, Gelita AGv, Catelent Inc., Rousselot, Sterling Gelatin, Norland Products Inc, Weishardt, Tessenderlo Group, Roxlor llc, Nitta Gelatin Inc, and other players.|
|Key Drivers||• Gelatin is more versatile and superior in pharmaceutical applications.
• Gelatin is a completely natural substance that complies with medical laws.
|Restraints||• Veganism is becoming more popular.
• Pharmaceutical gelatin production is constrained in some areas by cultural constraints.
Frequently Asked Questions (FAQ) :
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of Ukraine ware
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Pharmaceutical Gelatin Market Segmentation, By Application
8.1 Hard Capsules
8.2 Soft Capsules
8.4 Absorbable Hemostats
9. Pharmaceutical Gelatin Market Segmentation, By Source
9.2 Bovine Skin
9.3 Bovine Bone
10. Pharmaceutical Gelatin Market Segmentation, By Function
10.1 Stabilizing agents
10.2 Thickening agents
10.3 Gelling agents & Other Functions
11. Pharmaceutical Gelatin Market Segmentation, By Type
11.1 Type A
11.2 Type B
12. Regional Analysis
12.2 North America
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4.2 South Korea
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.3 South Africa
12.6 Latin America
12.6.3 Rest of Latin America
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 Gelita AGv
13.3 Catelent Inc.
13.5 Sterling Gelatin
13.6 Norland Products Inc
13.8 Tessenderlo Group
13.9 Roxlor llc
13.10 Nitta Gelatin Inc.
14.1 Competitive Benchmark
14.2 Market Share analysis
14.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of the good and accurate research report and selecting the best methodology to complete the research is the toughest part. Since the research reports, we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brainstorming sessions to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploaded on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.